Jiangsu Hengrui Medicine Co., Ltd.

This study tested whether adding the drug SHR3680 to standard hormone therapy could improve outcomes for men with high-risk prostate cancer who were scheduled for prostate removal surgery. The trial involved 391 participants and looked at how many had no cancer left in the remove…

This study tested a new inhaled medicine called HRG2005 in people with moderate to severe chronic obstructive pulmonary disease (COPD). About 82 participants were enrolled to see if the drug improves lung function compared to an active control. The trial was terminated early, so …